• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

PharmaJet, Serum Institute partner for needle-free MMR vaccine

March 8, 2017 By Sarah Faulkner

PharmaJet, Serum Institute partner for needle-free MMR vaccinePharmaJet inked a partnership with vaccine manufacturer Serum Institute of India to commercialize needle-free delivery of the MMR vaccine using the Stratis 0.5mL injection system.

PharmaJet’s device is designed to administer medication intramuscularly or subcutaneously, without the use of needles. The Chicago-based company touts the technology as a way to prevent cross-contamination between needles and enhance patient compliance.

The company completed a Phase IV clinical trial, funded by the Gates Foundation, which evaluated the needle-free system in more than 300 children aged 15-18 months over 1 year. The data showed non-inferiority performance and safety comparable to a traditional needle and syringe. The needle-free MMR vaccine will be available early this year, according to PharmaJet.

In India, it is estimated that 500 children die every day because of the measles.

“The PharmaJet device offers a safe, fast and easy alternative to traditional needle and syringe.  Making needle-free an available alternative for the MMR vaccine has the potential to increase immunization rates and save lives,” chairman & CEO Ron Lowy said in prepared remarks.

In February, PharmaJet said that a trivalent and quadrivalent influenza vaccine is available with its Stratis needle-free injector for this year’s flu season.

In October last year, the company inked a collaborative deal with Vaccibody to provide needle-free injection tech for the development of a human papillomavirus vaccine.

HPV is the cause of virtually all cervical cancer, according to the National Cancer Institute, and just 2 types of HPV, 16 and 18, are responsible for about 70% of all cases.

PharmaJet landed a multi-year partnership with the World Health Organization in August last year as part of the group’s effort to eradicate polio using the company’s needle-free tech.

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Wall Street Beat Tagged With: PharmaJet

IN CASE YOU MISSED IT

  • Nuvo, Sheba Medical Center develop AI-powered gestational diabetes management platform
  • Verily’s Onduo, Sword Health collaborate on virtual diabetes care
  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS